Tuberculosis (TB) is curable and preventable. However, TB kills 1.6 actor people a year (or 4,000 people a day) and is one of the top ten causes of death worldwide, according to the World Health Organization.

The stigma and adhering to a analysis regime are key affidavit this acutely communicable ache is still a risk.

According to the WHO, to beat TB, a accommodating must take four antimicrobial drugs for at least six months. But health admiral across the globe say that after administration and support, many TB patients will not finish their medications.

“Non-medical drivers of ache such as stigma, access to care challenges, crushing analysis protocols, and a lack of information, motivation, and abutment make it difficult for patients to do the right thing and take their medication,” said Jon Rathauser, CEO and architect of Israeli agenda health startup Keheala, in a statement on Thursday.

Keheala, a Tel Aviv-based startup with offices in Nairobi, Kenya is on a mission to advance healthcare access and analysis outcomes for patients.

First founded in 2014, Keheala developed a “low-tech” band-aid to help actuate analysis adherence and get patients to take their medications on time, using basic phone appearance – like SMS or text – and behavioral science strategies for a belvedere based on USSD – baggy added account data.

“This means patients can dial in (*694# in Kenya) and text Keheala,” Rathauser tells NoCamels. Shortcodes are accessible on 99 percent of basic affection phones. The belvedere deeply delivers reminders, ache advice and enable self-verification of treatment, simplifying and allegorical the action of care.

Here’s how it works: The affairs sends text letters to patients to take their meds on time. If the accommodating takes his meds, he sends a text back saying so and will get addition bulletin of thanks. If he doesn’t respond, more text letters are sent, followed by phone calls from Keheala supporters to verify adherence.

“They can accept a ‘push’ via SMS with reminders to take their meds, and they can self-verify that they took it, as well as affix with supporters and mentors,” says Rathauser, who is originally from New Jersey and holds public health and business degrees from McGill University and the Technion Institute. For example, if the system recognizes that there has been no action or ‘check-in,’ “a mentor can admit a text chat and ask how the person is doing and if they need anything.”


In this way, explains Dr. Erez Yoeli, a social scientist at MIT who helped to design the startup’s interventions, Keheala uses two key behavioral attempt to change accommodating behavior: both “increased observability” of patients and “eliminating believable deniability,” that is, abstinent patients the befalling to make excuses for missed treatments.

Keheala is not the first team to try and combat TB via reminders. It is the first to make use of a two-way system that bundles in best practices from the social sciences, whereby the accommodating had to actively verify that he or she followed the analysis regime.

“We use behavioral attitude to animate people to take their medication so they take care of themselves and their communities,” says Rathauser.

Indeed, Keheala also sends text letters to remind the patients that in taking their medications, they are befitting safe their families and friends. The name of the aggregation and platform, by no coincidence, is the Hebrew word for “community.”

The company’s slogan is “healing within the community” – “literal in the English spelling (Ke-heal-a) and allegorical for the association assurance access activated to access analysis adherence,” according to its website.

On Thursday, Keheala appear the allegation of a new study conducted in accord with MIT researchers, which showed that their system worked quite well.

In a 1,200-patient randomized controlled trial at 17 analytic sites in Kenya, 96 percent of the patients accomplished acknowledged outcomes, Keheala says.

The after-effects of that 2016 study were appear on Thursday in a paper titled “Digital Health Abutment in Analysis for Tuberculosis,” in the New England Journal of Medicine.


Read next: Robinhood users are bottomward appear loss-making companies